MGX
Metagenomi, Inc.
1.00$
-7.7%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 76.7% | 88.5% | 76.3% | 79.5% | 74.9% | |
| 27.7% | 44.5% | 38.5% | 8.4% | 18.9% | |
| 76.2% | 87.4% | 74.3% | 76.5% | 72.7% | |
| 0.3% | 0.3% | 0.7% | 0.4% | 0.1% | |
| 122.9% | 118.0% | 137.2% | 27.6% | 28.3% | |
| 17.7% | 11.7% | 18.9% | 11.5% | 10.4% | |
| 0.5% | 0.4% | 0.9% | 1.7% | 2.7% | |
| 1.0% | 0.5% | 0.5% | 0.2% | 0.7% | |
| 21.3% | – | – | – | – | |
| -22.9% | -18.0% | -37.2% | 72.4% | 71.7% | |
| -23.3% | -18.5% | -39.7% | -68.7% | -140.6% | |
| 4.2% | 9.0% | 10.3% | 11.5% | 16.8% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.